Synergistic and tunable human gene activation by combinations of synthetic transcription factors
Pablo Pérez‐Piñera(University of Illinois Urbana-Champaign), Charles A. Gersbach(Duke University), Gregory E. Crawford(Duke University), David G. Ousterout(Profectus Biosciences (United States)), Katherine A. Glass(Cornell University), Jonathan M. Brunger(Duke University), Farshid Guilak(Washington University in St. Louis), Alicia M. Farin(Duke Medical Center), Alexander J. Hartemink(Duke University)
Cited by 241
Related Papers
RNA-guided gene activation by CRISPR-Cas9–based transcription factors
|Nature Methods|2013|1.3k
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
|Science|2015|1.1k
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy
|Nature Communications|2015|456
Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector
|Nucleic Acids Research|2014|388
The role of macrophages in osteoarthritis and cartilage repair
|Osteoarthritis and Cartilage|2020|332